View Item 

Show simple item record

Mesenchymal stem cells alleviate bacteria‐induced liver injury in mice by inducing regulatory dendritic cells
dc.contributor.authorZhang, Yien_US
dc.contributor.authorCai, Weien_US
dc.contributor.authorHuang, Qingrongen_US
dc.contributor.authorGu, Yutingen_US
dc.contributor.authorShi, Yufangen_US
dc.contributor.authorHuang, Jiefangen_US
dc.contributor.authorZhao, Fangen_US
dc.contributor.authorLiu, Qiangen_US
dc.contributor.authorWei, Xunbinen_US
dc.contributor.authorJin, Minen_US
dc.contributor.authorWu, Changpingen_US
dc.contributor.authorXie, Qingen_US
dc.contributor.authorZhang, Yien_US
dc.contributor.authorWan, Bingen_US
dc.contributor.authorZhang, Yanyunen_US
dc.date.accessioned2014-02-11T17:57:23Z
dc.date.available2015-04-01T19:59:07Zen_US
dc.date.issued2014-02en_US
dc.identifier.citationZhang, Yi; Cai, Wei; Huang, Qingrong; Gu, Yuting; Shi, Yufang; Huang, Jiefang; Zhao, Fang; Liu, Qiang; Wei, Xunbin; Jin, Min; Wu, Changping; Xie, Qing; Zhang, Yi; Wan, Bing; Zhang, Yanyun (2014). "Mesenchymal stem cells alleviate bacteria‐induced liver injury in mice by inducing regulatory dendritic cells." Hepatology 59(2): 671-682.en_US
dc.identifier.issn0270-9139en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/102718
dc.publisherWiley Periodicals, Inc.en_US
dc.titleMesenchymal stem cells alleviate bacteria‐induced liver injury in mice by inducing regulatory dendritic cellsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/102718/1/hep26670.pdf
dc.identifier.doi10.1002/hep.26670en_US
dc.identifier.sourceHepatologyen_US
dc.identifier.citedreferenceMatta BM, Raimondi G, Rosborough BR, Sumpter TL, Thomson AW. IL‐27 production and STAT3‐dependent upregulation of B7‐H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells. J Immunol 2012; 188: 5227 ‐ 5237.en_US
dc.identifier.citedreferenceNauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE. Mesenchymal stem cells inhibit generation and function of both CD34+‐derived and monocyte‐derived dendritic cells. J Immunol 2006; 177: 2080 ‐ 2087.en_US
dc.identifier.citedreferenceYoneyama H, Narumi S, Zhang Y, Murai M, Baggiolini M, Lanzavecchia A, et al. Pivotal role of dendritic cell‐derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J Exp Med 2002; 195: 1257 ‐ 1266.en_US
dc.identifier.citedreferenceYoneyama H, Matsuno K, Zhang Y, Murai M, Itakura M, Ishikawa S, et al. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract‐associated lymphoid tissue, in a granulomatous liver disease. J Exp Med 2001; 193: 35 ‐ 49.en_US
dc.identifier.citedreferenceZhang Y, Yoneyama H, Wang Y, Ishikawa S, Hashimoto S, Gao JL, et al. Mobilization of dendritic cell precursors into the circulation by administration of MIP‐1alpha in mice. J Natl Cancer Inst 2004; 96: 201 ‐ 209.en_US
dc.identifier.citedreferenceXiao Y, Xu J, Mao C, Jin M, Wu Q, Zou J, et al. 18Beta‐glycyrrhetinic acid ameliorates acute Propionibacterium acnes‐induced liver injury through inhibition of macrophage inflammatory protein‐1alpha. J Biol Chem 2010; 285: 1128 ‐ 1137.en_US
dc.identifier.citedreferenceHattori T, Saban DR, Emami‐Naeini P, Chauhan SK, Funaki T, Ueno H, et al. Donor‐derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization‐dominant setting of corneal transplantation. J Leukoc Biol 2012; 91: 621 ‐ 627.en_US
dc.identifier.citedreferenceGrangette C. Bifidobacteria and subsets of dendritic cells: friendly players in immune regulation! Gut 2012; 61: 331 ‐ 332.en_US
dc.identifier.citedreferenceYen JH, Kocieda VP, Jing H, Ganea D. Prostaglandin E2 induces matrix metalloproteinase 9 expression in dendritic cells through two independent signaling pathways leading to activator protein 1 (AP‐1) activation. J Biol Chem 2011; 286: 38913 ‐ 38923.en_US
dc.identifier.citedreferenceCaparros E, Munoz P, Sierra‐Filardi E, Serrano‐Gomez D, Puig‐Kroger A, Rodriguez‐Fernandez JL, et al. DC‐SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 2006; 107: 3950 ‐ 3958.en_US
dc.identifier.citedreferenceChamberlain J, Yamagami T, Colletti E, Theise ND, Desai J, Frias A, et al. Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep. Hepatology 2007; 46: 1935 ‐ 1945.en_US
dc.identifier.citedreferenceSato K, Yamashita N, Baba M, Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft‐versus‐host disease and leukemia relapse. Immunity 2003; 18: 367 ‐ 379.en_US
dc.identifier.citedreferenceLutz MB, Schuler G. Immature, semi‐mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23: 445 ‐ 449.en_US
dc.identifier.citedreferenceMenges M, Rossner S, Voigtlander C, Schindler H, Kukutsch NA, Bogdan C, et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen‐specific protection of mice from autoimmunity. J Exp Med 2002; 195: 15 ‐ 21.en_US
dc.identifier.citedreferenceAkbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL‐10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725 ‐ 731.en_US
dc.identifier.citedreferencePopov A, Abdullah Z, Wickenhauser C, Saric T, Driesen J, Hanisch FG, et al. Indoleamine 2,3‐dioxygenase‐expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest 2006; 116: 3160 ‐ 3170.en_US
dc.identifier.citedreferenceCoombes JL, Siddiqui KR, Arancibia‐Carcamo CV, Hall J, Sun CM, Belkaid Y, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF‐βeta and retinoic acid‐dependent mechanism. J Exp Med 2007; 204: 1757 ‐ 1764.en_US
dc.identifier.citedreferenceTakagi H, Fukaya T, Eizumi K, Sato Y, Sato K, Shibazaki A, et al. Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity 2011; 35: 958 ‐ 971.en_US
dc.identifier.citedreferenceLi YP, Paczesny S, Lauret E, Poirault S, Bordigoni P, Mekhloufi F, et al. Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol 2008; 180: 1598 ‐ 1608.en_US
dc.identifier.citedreferenceBendelac A, Bonneville M, Kearney JF. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 2001; 1: 177 ‐ 186.en_US
dc.identifier.citedreferenceOchsenbein AF, Pinschewer DD, Odermatt B, Ciurea A, Hengartner H, Zinkernagel RM. Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design. J Immunol 2000; 164: 6296 ‐ 6302.en_US
dc.identifier.citedreferenceSchmidt LM, Belvisi MG, Bode KA, Bauer J, Schmidt C, Suchy MT, et al. Bronchial epithelial cell‐derived prostaglandin E2 dampens the reactivity of dendritic cells. J Immunol 2011; 186: 2095 ‐ 2105.en_US
dc.identifier.citedreferenceHarizi H, Gualde N. Pivotal role of PGE2 and IL‐10 in the cross‐regulation of dendritic cell‐derived inflammatory mediators. Cell Mol Immunol 2006; 3: 271 ‐ 277.en_US
dc.identifier.citedreferenceKim J, Hematti P. Mesenchymal stem cell‐educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 2009; 37: 1445 ‐ 1453.en_US
dc.identifier.citedreferenceZhang QZ, Su WR, Shi SH, Wilder‐Smith P, Xiang AP, Wong A, et al. Human gingiva‐derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 2010; 28: 1856 ‐ 1868.en_US
dc.identifier.citedreferencevan Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, et al. Mesenchymal stem cell‐derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008; 47: 1634 ‐ 1643.en_US
dc.identifier.citedreferencePeng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short‐term and long‐term outcomes. Hepatology 2011; 54: 820 ‐ 828.en_US
dc.identifier.citedreferenceYoneyama H, Harada A, Imai T, Baba M, Yoshie O, Zhang Y, et al. Pivotal role of TARC, a CC chemokine, in bacteria‐induced fulminant hepatic failure in mice. J Clin Invest 1998; 102: 1933 ‐ 1941.en_US
dc.identifier.citedreferenceHoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995; 21: 240 ‐ 252.en_US
dc.identifier.citedreferenceMoniaux N, Song H, Darnaud M, Garbin K, Gigou M, Mitchell C, et al. Human hepatocarcinoma‐intestine‐pancreas/pancreatitis‐associated protein cures fas‐induced acute liver failure in mice by attenuating free‐radical damage in injured livers. Hepatology 2011; 53: 618 ‐ 627.en_US
dc.identifier.citedreferenceNemes B, Gelley F, Piros L, Zadori G, Gorog D, Fehervari I, et al. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program. Transplant Proc 2011; 43: 1272 ‐ 1274.en_US
dc.identifier.citedreferenceShi Y, Hu G, Su J, Li W, Chen Q, Shou P, et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010; 20: 510 ‐ 518.en_US
dc.identifier.citedreferencePileggi A. Mesenchymal stem cells for the treatment of diabetes. Diabetes 2012; 61: 1355 ‐ 1356.en_US
dc.identifier.citedreferencePapadopoulou A, Yiangou M, Athanasiou E, Zogas N, Kaloyannidis P, Batsis I, et al. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann Rheum Dis 2012; 71: 1733 ‐ 1740.en_US
dc.identifier.citedreferenceLi W, Ren G, Huang Y, Su J, Han Y, Li J, et al. Mesenchymal stem cells: a double‐edged sword in regulating immune responses. Cell Death Differ 2012; 19: 1505 ‐ 1513.en_US
dc.identifier.citedreferenceAquino JB, Bolontrade MF, Garcia MG, Podhajcer OL, Mazzolini G. Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma. Gene Ther 2010; 17: 692 ‐ 708.en_US
dc.identifier.citedreferenceAdler HS, Steinbrink K. Tolerogenic dendritic cells in health and disease: friend and foe! Eur J Dermatol 2007; 17: 476 ‐ 491.en_US
dc.identifier.citedreferenceLiu X, Qu X, Chen Y, Liao L, Cheng K, Shao C, et al. Mesenchymal stem/stromal cells induce the generation of novel IL‐10‐dependent regulatory dendritic cells by SOCS3 activation. J Immunol 2012; 189: 1182 ‐ 1192.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep26670.pdf
Size:
1.130MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.